Research Article
[Retracted] Meta-Analysis of the Effectiveness and Safety of Glucocorticoid for the Treatment of IgA Kidney Disease
Table 4
Effect of short-term (<1 year) course of glucocorticoid on proteinuria in IgA nephropathy.
| Glucocorticoid group | Control group | Std. mean difference | Study or subgroup | Mean | SD | Total | Mean | SD | Total | Weight | IV, fixed, 95% CI |
| Locatelli et al., 2001 | 0.67 | 0.5 | 43 | 1.48 | 1.87 | 43 | 66.4% | −0.59 [−1.02,−0.15] | Uzu T et al., 2003 | −1.26 | 0.56 | 23 | −0.86 | 0.45 | 22 | 33.6% | −0.77 [−1.38,−0.16] | Total (95% CI) | | | 66 | | | 65 | 100.0% | −0.65 [−1.00,−0.30] |
|
|
Heterogeneity: Chi’ = 0.24, df = 1 ( = 0.63); I2 = 0%. Test for overall effect: Z = 3.61 ( = 0.0003). |